| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
0 | - | 0 | - | 0 | - | 0 | - | - | - |
Operating expenses: | |||||||||
Research and development | |||||||||
5,883 | 5,108 | 4,525 | 3,812 | 4,422 | 4,669 | 0 | 0 | 0 | 0 |
Sales and marketing | |||||||||
183 | 189 | 263 | 339 | 349 | 304 | 0 | 0 | 0 | 0 |
Depreciation and amortization | |||||||||
257 | 216 | 176 | 132 | 119 | 120 | 0 | 0 | 0 | 0 |
General and administrative | |||||||||
7,506 | 7,428 | 6,749 | 5,780 | 4,513 | 3,107 | 0 | 0 | 0 | 0 |
Total operating expenses | |||||||||
13,831 | 12,943 | 11,714 | 10,065 | 9,404 | 8,202 | 0 | 0 | 0 | 0 |
Loss from operations | |||||||||
-13,831 | -12,943 | -11,714 | -10,065 | -9,404 | -8,202 | 0 | 0 | 0 | 0 |
Other (expense) income: | |||||||||
Interest expense | |||||||||
0 | 822 | 1,190 | 1,518 | 1,771 | 1,115 | 0 | 0 | 0 | 0 |
Interest income | |||||||||
0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - |
Other income | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Total other income (expense) | |||||||||
17 | -808 | -1,181 | -1,514 | -1,766 | -1,112 | 0 | 0 | 0 | 0 |
Loss before income taxes | |||||||||
- | - | - | -11,580 | - | - | - | 0 | 0 | 0 |
Net loss | |||||||||
-13,814 | -13,751 | -12,896 | -11,580 | -11,171 | -9,314 | 0 | 0 | 0 | 0 |
Dividend to Series A and B preferred stockholders | |||||||||
0 | 160 | 480 | 800 | 1,120 | 1,280 | 0 | 0 | 0 | 0 |
Net loss attributable to common stockholders | |||||||||
-13,814 | -13,912 | -13,376 | -12,380 | -12,291 | -10,594 | 0 | 0 | 0 | 0 |
Net loss per common share, basic and diluted (in dollars per share) | |||||||||
-0.19 | -0.10 | -0.27 | -0.20 | -0.43 | -1.42 | -1.74 | -1.56 | -0.92 | -1.12 |
Weighted average number of common shares outstanding, basic and diluted (in shares) | |||||||||
16,781 | 16,827 | 15,994 | 14,801 | 7,745 | 1,947 | 1,898 | 1,845 | 1,820 | 1,720 |